Enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by daf-2 based on microarray studies. Is affected by triclosan based on microarray studies.
Enriched in NSM; Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on tiling array and RNA-seq studies. Is affected by rsr-2 and clk-1 based on tiling array and microarray studies.
Predicted to enable protein tyrosine phosphatase activity. Human ortholog(s) of this gene implicated in gastric adenocarcinoma. Is an ortholog of human PTPRG (protein tyrosine phosphatase receptor type G) and PTPRZ1 (protein tyrosine phosphatase receptor type Z1).
Predicted to enable sugar transmembrane transporter activity. Predicted to be involved in carbohydrate transport. Predicted to be located in Golgi membrane. Expressed in Z1; Z4; and spermatheca. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).
Predicted to enable protein tyrosine phosphatase activity. Predicted to be involved in motor neuron axon guidance. Human ortholog(s) of this gene implicated in gastric adenocarcinoma. Is an ortholog of human PTPRG (protein tyrosine phosphatase receptor type G) and PTPRZ1 (protein tyrosine phosphatase receptor type Z1).
Enriched in Z1; Z4; and somatic gonad precursor based on RNA-seq and single-cell RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including allantoin; metformin; and Psoralens based on RNA-seq studies.